586 related articles for article (PubMed ID: 34097314)
21. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Qin H; Zhao A
Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
[TBL] [Abstract][Full Text] [Related]
22. Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
Jahangir CA; Page DB; Broeckx G; Gonzalez CA; Burke C; Murphy C; Reis-Filho JS; Ly A; Harms PW; Gupta RR; Vieth M; Hida AI; Kahila M; Kos Z; van Diest PJ; Verbandt S; Thagaard J; Khiroya R; Abduljabbar K; Acosta Haab G; Acs B; Adams S; Almeida JS; Alvarado-Cabrero I; Azmoudeh-Ardalan F; Badve S; Baharun NB; Bellolio ER; Bheemaraju V; Blenman KR; Botinelly Mendonça Fujimoto L; Burgues O; Chardas A; Cheang MCU; Ciompi F; Cooper LA; Coosemans A; Corredor G; Dantas Portela FL; Deman F; Demaria S; Dudgeon SN; Elghazawy M; Fernandez-Martín C; Fineberg S; Fox SB; Giltnane JM; Gnjatic S; Gonzalez-Ericsson PI; Grigoriadis A; Halama N; Hanna MG; Harbhajanka A; Hart SN; Hartman J; Hewitt S; Horlings HM; Husain Z; Irshad S; Janssen EA; Kataoka TR; Kawaguchi K; Khramtsov AI; Kiraz U; Kirtani P; Kodach LL; Korski K; Akturk G; Scott E; Kovács A; Laenkholm AV; Lang-Schwarz C; Larsimont D; Lennerz JK; Lerousseau M; Li X; Madabhushi A; Maley SK; Manur Narasimhamurthy V; Marks DK; McDonald ES; Mehrotra R; Michiels S; Kharidehal D; Minhas FUAA; Mittal S; Moore DA; Mushtaq S; Nighat H; Papathomas T; Penault-Llorca F; Perera RD; Pinard CJ; Pinto-Cardenas JC; Pruneri G; Pusztai L; Rajpoot NM; Rapoport BL; Rau TT; Ribeiro JM; Rimm D; Vincent-Salomon A; Saltz J; Sayed S; Hytopoulos E; Mahon S; Siziopikou KP; Sotiriou C; Stenzinger A; Sughayer MA; Sur D; Symmans F; Tanaka S; Taxter T; Tejpar S; Teuwen J; Thompson EA; Tramm T; Tran WT; van der Laak J; Verghese GE; Viale G; Wahab N; Walter T; Waumans Y; Wen HY; Yang W; Yuan Y; Bartlett J; Loibl S; Denkert C; Savas P; Loi S; Specht Stovgaard E; Salgado R; Gallagher WM; Rahman A
J Pathol; 2024 Mar; 262(3):271-288. PubMed ID: 38230434
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructure of cell trafficking pathways and coronavirus: how to recognise the wolf amongst the sheep.
Neil D; Moran L; Horsfield C; Curtis E; Swann O; Barclay W; Hanley B; Hollinshead M; Roufosse C
J Pathol; 2020 Dec; 252(4):346-357. PubMed ID: 32918747
[TBL] [Abstract][Full Text] [Related]
24. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
25. The value of cell-free DNA for molecular pathology.
Stewart CM; Kothari PD; Mouliere F; Mair R; Somnay S; Benayed R; Zehir A; Weigelt B; Dawson SJ; Arcila ME; Berger MF; Tsui DW
J Pathol; 2018 Apr; 244(5):616-627. PubMed ID: 29380875
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
Harrell CR; Jovicic BP; Djonov V; Volarevic V
Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
[TBL] [Abstract][Full Text] [Related]
27. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
28. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
29. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.
Wang C; Xie J; Zhao L; Fei X; Zhang H; Tan Y; Nie X; Zhou L; Liu Z; Ren Y; Yuan L; Zhang Y; Zhang J; Liang L; Chen X; Liu X; Wang P; Han X; Weng X; Chen Y; Yu T; Zhang X; Cai J; Chen R; Shi ZL; Bian XW
EBioMedicine; 2020 Jul; 57():102833. PubMed ID: 32574956
[TBL] [Abstract][Full Text] [Related]
30. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
31. Re-interpreting tumour behaviour and the tumour microenvironment as normal responses to tissue disorganisation.
Edwards PA
J Pathol; 2023 May; 260(1):1-4. PubMed ID: 36811403
[TBL] [Abstract][Full Text] [Related]
32. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
Zhang Z; Li L; Li M; Wang X
Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.
Trevisan M; Riccetti S; Sinigaglia A; Barzon L
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652988
[TBL] [Abstract][Full Text] [Related]
34. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.
Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F
Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
Zhang T; Sun LX; Feng RE
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
Suh SH; Ma SK; Kim SW; Bae EH
Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
[TBL] [Abstract][Full Text] [Related]
37. A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
Silva TF; Tomiotto-Pellissier F; Sanfelice RA; Gonçalves MD; da Silva Bortoleti BT; Detoni MB; Rodrigues ACJ; Carloto ACM; Concato VM; Siqueira EDS; Costa IN; Pavanelli WR; Conchon-Costa I; Miranda-Sapla MM
Front Immunol; 2020; 11():562264. PubMed ID: 33193331
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.
Ogino S; Nowak JA; Hamada T; Phipps AI; Peters U; Milner DA; Giovannucci EL; Nishihara R; Giannakis M; Garrett WS; Song M
Gut; 2018 Jun; 67(6):1168-1180. PubMed ID: 29437869
[TBL] [Abstract][Full Text] [Related]
39. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
40. Generation of Complete Multi-Cell Type Lung Organoids From Human Embryonic and Patient-Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation.
Leibel SL; McVicar RN; Winquist AM; Niles WD; Snyder EY
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e118. PubMed ID: 32640120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
